期刊文献+

肝肾综合征发生的危险因素及防治 被引量:9

Prevention of risk factors and treatment of hepatorenal syndrome
原文传递
导出
摘要 肝肾综合征是各种原因引起的终末期肝病的常见严重并发症,缺乏有效的治疗措施,病死率高。该文对其临床分型、诊断、预防和治疗进行了介绍,以帮助临床医生对肝肾综合征进行有效的预防和正确的治疗。 Hepatorenal syndrome (HRS) is a well-recognized complication of end-stage liver disease which carriers a poor prognosis and high mortality rate without transplantation. The pathophysiological mechanisms of HRS are characterized by significant hemodynamic changes. These changes consist of systemic arterial vasodilatation and effective arterial underfilling. The purpose of the present paper is to provide a review of the pathophysiology, risk factors, preventions, and therapies on HRS.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2013年第9期687-689,共3页 Chinese Journal of Practical Internal Medicine
关键词 肝肾综合征 终末期肝病 自发性细菌性腹膜炎 消化道出血 肝移植 hepatorenal syndrome end-stage liver disease spontaneous bacterial peritonitis alimentary tract hemorrhage liv-er transplantation
  • 相关文献

参考文献6

  • 1Wadei HM, Mai LM, Ahsan N, et al. In depth review hepatorenal syndrone:pathopbysiology and management [ J ]. Clin J AM Soc Nephrol,2006,1 (2) : 1066 - 1079.
  • 2European Association for the Study of the Liver. EASL clinical prac- tice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis [ J ]. J Hepatol, 2010,53(3 ) :397 -417.
  • 3Ruiz R, Barri YM,Jennings LM, et al. Hepatorenal syndrome : a pro- posal for kidney after liver transplantation(KALT) [ J] Liver trans- plantation,2007,13 (6) :838 - 843.
  • 4Rena NM, Wibawa ID. Albumin infusion in liver cirrhotic patients[ J]. Acta Med Indones.2010.42 (3) : 162 -168.
  • 5钟渊斌,张伦理.奥曲肽联合清蛋白及呋塞米治疗肝肾综合征的临床疗效研究[J].中国全科医学,2012,15(12):1350-1352. 被引量:17
  • 6Moller S, Aagaard NK, Schmidt L, et al. Treatment of the hepatore- nal syndrome and hyponatremia in cirrhosis-part 1I [ J ]. Dan Med J,2012,59( 1 ) : C4372.

二级参考文献7

  • 1Wadei HM,Mai ML,Ahsan N. Hepatorenal syndrome:pathophysiology and management[J].Clin J Am Soc Nephrol,2006,(05):1066-1079.
  • 2Salerno F,Gerbes A,Gines P. Diagnosis,prevention and treatment of hepatorenal syndrome in cirrhosis[J].Gut,2007,(09):1310-1318.
  • 3张彤;梅长林.肝肾综合征的发病机制和治疗进展[J]肝脏,2008(增刊):49-52.
  • 4徐道振.病毒性肝炎临床实践[M]北京:人民卫生出版社,2006388-389.
  • 5Esrailian E,Pantangco ER,Kyulo NL. Octrcotide midodrine therapy significantly improves renal function and 30-day survivalin patients with typehepatorenal syndrome[J].Digest Dis and Scienc,2007,(03):742-748.
  • 6潘勤,李定国,杜学良,徐芹芳.生长抑素及奥曲肽的肝细胞保护作用及其机制研究[J].中国病理生理杂志,2008,24(4):730-733. 被引量:18
  • 7刘苏,何维新,谢渭芬.肝肾综合征的治疗现状[J].中华肝脏病杂志,2003,11(10):638-640. 被引量:10

共引文献16

同被引文献69

引证文献9

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部